Ensuring Complete Coverage of Medication-Assisted Treatment Act
A BILL
To amend title XIX of the Social Security Act to require States to include under their State Medicaid plans coverage for medication-assisted treatment, and for other purposes.
Sec. 2 Requirement for State Medicaid plans to provide coverage for medication-assisted treatment
“(29) beginning, subject to paragraph (2) of subsection (ee), January 1, 2020, medication-assisted treatment (as defined in paragraph (1) of such subsection); and”
“(ee) Medication-Assisted treatment defined; Waivers
“(1) Medication-assisted treatment defined—For purposes of subsection (a)(29), the term “medication-assisted treatment”—
“(A) means all drugs approved under section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355), including methadone, and all biological products licensed under section 351 of the Public Health Service Act (42 U.S.C. 262) to treat substance use disorders; and
“(B) includes, with respect to the provision of such drugs and biological products, counseling services and behavioral therapy.
“(2) Waivers—For purposes of subsection (a)(29), the Secretary may grant a waiver, with respect to a State, to delay the application of such subsection if the State submits a waiver request that includes the following:
“(A) The reasoning for such waiver.
“(B) A timeline for the State to implement the requirement of such subsection.
“(C) A review of any prior authorization program and any drug utilization management program established by the State under the State plan (or a waiver of such plan) to assess the types of barriers that individuals encounter in accessing medication-assisted treatment (as defined in paragraph (1)) under such plan (or waiver).
“(D) Any other information that the Secretary may require.”